Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lofexidine PK and Safety in Renally-Impaired Subjects
NCT02313103Phase 1Completed
- Sponsor
- US WorldMeds
- Start
- Nov 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of lofexidine in opioid withdrawal (2 arms), sponsored by US WorldMeds. Primary endpoint: Pharmacokinetic Profile. Started Nov 2014; status: completed.
02
Drugs
lofexidine
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on NCT02313103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02313103.